BSX vs DXCM — Key Metrics
| Metric | BSX (BOSTON SCIENTIFIC CORP) | DXCM (DEXCOM INC) |
|---|---|---|
| Price | 43.65 | 86.29 |
| Market Cap | 63.26 Billion | 32.56 Billion |
| P/E (TTM) | 17.53 | 33.32 |
| P/B (Quarterly) | 2.815 | 10.73 |
| P/S (TTM) | 3.01 | 6.55 |
| Net Profit Margin (TTM) | 17.5 | 20.1 |
| Gross Margin (TTM) | 69.9 | 62.5 |
| ROE (TTM) | 14.9 | 36.2 |
| Revenue Growth YoY (TTM) | None | None |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
BSX · BOSTON SCIENTIFIC CORP
Greatly Outperform
DXCM · DEXCOM INC
Outperform
Recommendation Summary
Stock BSX is projected to greatly outperform the market, stock DXCM is projected to outperform the market. Upfront Recommendation: BSX.
Financial Metrics
Prices delayed ~15 min
| BSX | Metrics | DXCM |
|---|---|---|
| $43.65 | Price | $86.29 |
| — | Market Capitalization | — |
| 17.53 | Price to Earnings Ratio | 33.32 |
| 3.01 | Price to Sales | 6.55 |
| 17.45 | Price to FCF Ratio | 23.18 |
| 4.31 | Price to Gross Profit | 10.49 |
| 29.38 | Price to R&D | 53.91 |
| 7.94 | Price to Current Assets | 7.97 |